AI assistant
Sending…
STANDARD BIOTOOLS INC. — Director's Dealing 2018
Mar 22, 2018
32853_dirs_2018-03-21_1ed2c259-acdf-4500-8144-cc43842685a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2018-03-19
Reporting Person: McPhail Steven (Chief Commercial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-19 | Employee Stock Option (Right to Buy) | $6.33 | A | 16200 | Acquired | 2028-03-19 | Common Stock (16200.0) | Direct |
Footnotes
F1: 12/48th of the total number of shares subject to the Option will vest on March 19, 2019 and 1/48th of the total shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that the Option will be fully vested on March 19, 2022, subject to the recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through each applicable vest date.
More from STANDARD BIOTOOLS INC.
M&A Activity
2026
Jun 8
M&A Activity
2026
Jun 8
Regulatory Filings
2026
Jun 5
Board/Management Information
2026
Jun 3
Regulatory Filings
2026
May 29
Board/Management Information
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3